Clinical Trial Update: Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 trial evaluating generic tazarotene cream 0.1% for acne vulgaris, which has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Tazarotene 0.1% Cream (generic) (tazarotene)

Snippet

Sponsor: G & W Laboratories Inc. | Conditions: Acne Vulgaris | Phase 3 | Status: COMPLETED